It was first identified for its role in colon cancer by forming complexes with the tumor suppressor adenomatous polyposis gene (APC) which was followed by characterization of β-catenin mutation in patients with colon cancer 13,14. This evidence concerns the gene APC and malignant colon neoplasm.